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Editorial on the Research Topic
Immunomodulatory Functions of Nutritional Ingredients in Health and Disease
Nutritional immunology is a rapidly developing field. An expanding body of evidence demonstrate
the impact of foods and nutritional components on gut and systemic immunity of consumers.
During recent years, the implications of nutrition and nutritional intervention on prevention of
disease have become accepted and has become an important tool inmanagement of several diseases.
Nutritional immunology might become even more important in prevention of disease when
the interplay between nutritional processes and immune system is better understood. Particularly,
specific cellular and molecular immune responses provoked by nutrition and the role of the gut
barrier and microbiota in the interplay needs more study.
This content of this Research Topic was designed to provide a timely collection on mechanistic,
translational, and clinical research on the interplay between foods, nutritional components, and
immunity in physiological and pathophysiological conditions.
We have a series of original or review articles featuring the role of gut microbiota impacted by
various factors, specific probiotics in shaping immunity and implications in immune inflammatory
diseases.
Fransen et al. focused on aged gut microbiota and health. Advanced age is associated with
chronic low-grade inflammation, referred to as inflammaging. The elderly are also known to harbor
an altered gut microbiota composition. It was unknown whether this altered gut microbiota was
cause or consequence of inflammaging. To this end, Fransen et al. performed microbiota transfer
from old mice to germ free young mice and demonstrated that the gut microbiota from old mice
contributes to inflammaging after transfer to youngGFmice. This knowledgemight lead to targeted
strategies to juvenile the microbiota in elderly to reduce inflammaging.
Besides aging, gender affects the immune system and gut microbiota composition. Also here
cause or consequence was unknown. In this context, the same group demonstrate that gender
differences in immunity are already present in GF mice, independent of gut microbiota and that
microbiota-independent gender differences in the immune system select a gender-specific gut
microbiota composition, which in turn further contributes to gender differences in the immune
system (Fransen et al.). This research suggests that modulation of immunity by nutrition might
need a gender specific approach.
Accumulating evidence supports an important role of diet and gut microbiota in immune-
mediated diseases. Multiple sclerosis (MS) is an autoimmune neurological disease characterized
by chronic inflammation of the central nervous system (CNS), leading to demyelination, axonal
damage, and symptoms such as fatigue and disability. The infiltration of peripherally activated
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immune cells into the CNS has a key pathogenic role. Preclinical
as well as clinical studies suggest a role for gut microbiota and
dietary components in MS. The review from van Den Hoogan
et al. focused on recent studies on gut microbiota and dietary
interventions in MS and prospective animal models in which
efficacy of dietary intervention can be tested.
In this Research Topic, we have also several studies focusing
on different specific probiotic strains to modulate immune-
related conditions. An imbalance in gut microbiota composition
can lead to impaired intestinal homeostasis, chronic gut
inflammation and a predisposition to developing, for example,
colorectal cancer (CRC). The use of probiotic bacteria has
emerged as an additive strategy to treat and prevent cancer.
Moreover, consumption of beneficial bacteria may favorably
modulate the composition of gut microbiota, which has
been described in several studies to play an important role
in preventing CRC carcinogenesis. In this regard, Jacouton
et al. assessed the protective effect of oral treatment with
Lactobacillus casei BL23, a probiotic strain well-known for its
anti-inflammatory and anticancer properties in CRC. Their
results demonstrate high potential of L. casei BL23 for the
development of new, probiotic-based strategies to fight CRC.
Oral bacteria interact with intestinal mucosa and impact
immunity. However, mechanistic insights are limited. de Vos
et al. conducted a randomized placebo-controlled cross-over
trial, to evaluate Lactobacillus plantarum supplementation (strain
TIFN101, CIP104448, or WCFS1) or placebo in healthy human
subjects for 7 days. Their data show that specific bacterial
strains can prevent immune stress induced by commonly
consumed painkillers such as non-steroidal anti-inflammatory
drug (NSAID) and can have enhancing beneficial effects on
immunity of consumers by stimulating antigen presentation
and memory responses. This study demonstrates that probiotic
species can serve as a mean to prevent side-effects of medication.
Indigenous Clostridium species have been recently
demonstrated to induce colonic regulatory T cells (Tregs),
and gut lymphocytes are able to migrate to pancreatic islets
in an inflammatory environment. Jia et al. investigated
whether supplementation with the well-characterized probiotics
Clostridium butyricum CGMCC0313.1 (CB0313.1) may induce
pancreatic Tregs and consequently dampen the diabetes
incidence in non-obese diabetic (NOD) mice. This study provide
the basis for future clinical investigations in preventing type 1
diabetes (T1D) by oral CB0313.1 administration.
In another animal model for T1D, in biobreeding diabetes-
prone rats, it has been demonstrated that Lactobacillus johnsonii
N6.2 mitigated the onset of diabetes, in part, through changes
in kynurenine:tryptophan (K:T) ratios. As a step toward human
application, Marcial et al. performed a pilot double-blind,
randomized clinical trial to determine the safety, tolerance, and
general immunological response of L. johnsonii N6.2 in healthy
subjects. Forty-two healthy individuals with no known risk
factors for T1D were involved to evaluate subject responses to the
consumption of L. johnsonii N6.2. The data provide support for
the safety and feasibility of using L. johnsonii N6.2 in prevention
trials in subjects at risk for T1D.
Acute pancreatitis (AP) is a common abdominal inflammatory
disorder and one of the leading causes of hospital admission
for gastrointestinal disorders. No specific pharmacological or
nutritional therapy is available but highly needed. In this
Research Topic, Pan et al. provided a comprehensive review on
recent advances on nutritional treatment of acute pancreatitis,
focusing on enteral vs. parenteral nutrition strategies, and
nutritional supplements such as probiotics, glutamine, omega-3
fatty acids, and vitamins in clinical AP. The review gives several
leads to successful nutrition and nutritional supplements for
clinical management of AP.
In addition, the same group have focused on dietary
fibers in preventing or treating AP. Inulin-type fructans
(ITFs) are capable of modifying gut immune and barrier
homeostasis in a chemistry-dependent manner and hence
potentially applicable for managing AP, but their efficacy in
AP has not been demonstrated yet. He et al. examined and
compared modulatory effects of ITFs with different degrees
of fermentability on pancreatic-gut immunity and barrier
function during experimentally induced AP in mice. The results
demonstrate a clear chain length-dependent effect of inulin to
alleviate AP.
Obesity and metabolic syndrome are currently recognized
as worldwide epidemics that pose a profound socioeconomic
impact and represent a concern to public health. Cells of the
immune system contribute to both the maintenance of “lean
homeostasis” and metabolic dysregulation observed in obese
individuals. Mounting evidence suggest that food additives may
also be important contributors to metabolic derangement. The
latest review from Paula Neto et al. summarizes latest literature
evidence that food additives have relevant effects on cells of
the immune system that could contribute to immune-mediated
metabolic dysregulation. The reviewed data suggest that some
food additives should be avoided considering the adverse effects
of these additives to predispose individuals to develop obesity and
metabolic syndrome.
In another aspect, sexual dimorphism in immune response
is widely recognized, but few human studies have observed this
distinction. Food with endo-immunomodulatory potential may
reveal novel sex-biased in vivo interactions. To this end, Jumat
et al. compared immunomodulatory effects of Carica papaya
compared between healthy male and female individuals. Their
data show clear dissimilar immune profiles are elicited in the
sexes after papaya consumption and may have sex hormone
influence.
Lastly, we have two articles focusing on nutrient effects on
health and diseases. Excessive sodium intake is often associated
with high risk for cardiovascular disease. More recently, high-salt
diets (HSDs) have been demonstrated to activate Th17 cells and
increase severity of autoimmune diseases. Aguiar et al. evaluated
the effects of a diet supplemented with NaCl in the colonic
mucosa at steady state and during inflammation. They found that
consumption of HSD per se triggered a histologically detectable
inflammation in the colon and also exacerbated chemically
induced models of colitis in mice by a mechanism dependent on
IL-17 production most likely by both ILC3 and Th17 cells.
Frontiers in Immunology | www.frontiersin.org 2 January 2019 | Volume 10 | Article 50
Sun and de Vos Nutritional Ingredients and Host Immunity
L-arginine deficiency is shown to be associated with a growing
number of diseases in humans, including trauma, certain cancers,
and infection. L-arginine supplementation is essential during
pregnancy to support fetal development. In conditions of l-
arginine depletion, T cell proliferation is impaired. Previously,
it has been shown that neonatal blood has lower l-arginine
levels than adult blood, which is associated with poor
neonatal lymphocyte proliferation, and that l-arginine enhances
neonatal lymphocyte proliferation through an interleukin (IL)-
2-independent pathway. Yu et al. have further investigated
how exogenous l-arginine enhances neonatal Treg function in
relation to IL-10 production under epigenetic regulation. Their
results suggest that l-arginine modulates neonatal Tregs through
the regulation of IL-10 promoter DNA methylation. L-arginine
supplementationmay correct the Treg function in newborns with
l-arginine deficiency.
The scientific contributions collectively show the important
role of dietary components in immune homeostasis and the
potential of specific food ingredients to prevent disease or
manage disease symptoms. Insights in how specific food
components might impact gut microbiota, barrier function
or immunity-receptors might lead to targeted and rationally
designed strategies to avoid immune related diseases. At the same
time, the Research Topic shows that some ingredients may have
adverse effects and should be avoided in sensitive subjects and
that targeted groups such as different genders and age-classes
have to be distinguished for optimal efficacy of nutritional
interventions.
AUTHOR CONTRIBUTIONS
All authors listed have made a substantial, direct and intellectual
contribution to the work, and approved it for publication.
FUNDING
This paper and related work was supported by funds
from the National Natural Science Foundation of China
(Grant Nos.: 91642114, 31570915, and 81870439), Jiangsu
Province Recruitment Plan for the High-level, Innovative and
Entrepreneurial Talents (Top Talent of Innovative Research
Team), the Fundamental Research Funds for the Central
Universities (Grant No.: JUSRP51613A), Wuxi Science &
Technology Development Funds for International Science &
Technology R&D Cooperation (WX0303B010518180007PB)
and the National First-class Discipline Program of Food Science
and Technology (Grant No.: JUFSTR20180103).
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2019 Sun and de Vos. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The
use, distribution or reproduction in other forums is permitted, provided the
original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Immunology | www.frontiersin.org 3 January 2019 | Volume 10 | Article 50
